Flagship Harbor Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,629
| Closed | -$192K | – | 782 |
|
|
2024
Q3 | $192K | Buy |
+10,629
| New | +$192K | 0.01% | 700 |
|
|
2020
Q4 | – | Sell |
-2,671
| Closed | -$24K | – | 1612 |
|
|
2020
Q3 | $24K | Buy |
2,671
+2,344
| +717% | +$21.1K | ﹤0.01% | 1088 |
|
|
2020
Q2 | $4K | Hold |
327
| – | – | ﹤0.01% | 1651 |
|
|
2020
Q1 | $3K | Buy |
327
+100
| +44% | +$917 | ﹤0.01% | 1578 |
|
|
2019
Q4 | $2K | Hold |
227
| – | – | ﹤0.01% | 1731 |
|
|
2019
Q3 | $1K | Hold |
227
| – | – | ﹤0.01% | 1773 |
|
|
2019
Q2 | $2K | Hold |
227
| – | – | ﹤0.01% | 1701 |
|
|
2019
Q1 | $3K | Buy |
227
+60
| +36% | +$793 | ﹤0.01% | 1622 |
|
|
2018
Q4 | $2K | Sell |
167
-200
| -54% | -$2.4K | ﹤0.01% | 1652 |
|
|
2018
Q3 | $8K | Sell |
367
-408
| -53% | -$8.89K | ﹤0.01% | 1546 |
|
|
2018
Q2 | $18K | Buy |
+775
| New | +$18K | ﹤0.01% | 1150 |
|